BRIEF published on 04/29/2026 at 00:05, 4 months 13 days ago LIR Life Sciences lance une étude ex vivo sur l'efficacité de la protamine par voie transdermique. Accouchement Sans Aiguille Amélioration De La Protamine Transport Transdermique Molécules Thérapeutiques Étude Ex Vivo
BRIEF published on 04/29/2026 at 00:05, 4 months 13 days ago Onco-Innovations Successfully Scales Up Key Materials for PNKP Inhibitor Program Drug Development Pharmaceutical Manufacturing Scale-up Onco-Innovations PNKP Inhibitor
BRIEF published on 04/29/2026 at 00:05, 4 months 13 days ago Onco-Innovations réussit à industrialiser la production de matériaux clés pour son programme d'inhibiteurs de PNKP. Développement De Médicaments Fabrication Pharmaceutique Onco-Innovations Inhibiteur De PNKP Mise À L'échelle
BRIEF published on 04/28/2026 at 23:55, 4 months 13 days ago Gabriel Resources Secures $1.5 Million Bridge Loan Amid Financial Strains Gabriel Resources Bridge Loan Financial Strain Proposed Financing ICSID Tribunal
BRIEF published on 04/28/2026 at 23:55, 4 months 13 days ago Gabriel Resources obtient un prêt-relais de 1,5 million de dollars en pleine crise financière Ressources Gabriel Prêt Relais Financement Proposé Pressions Financières Tribunal CIRDI
BRIEF published on 04/28/2026 at 23:05, 4 months 13 days ago Rocky Mountain Liquor Reports 2025 Financial Results Adjusted EBITDA Growth Rocky Mountain Liquor Gross Margin Improvement Store Closures Financial Results 2025
BRIEF published on 04/28/2026 at 23:05, 4 months 13 days ago Rocky Mountain Liquor publie ses résultats financiers pour 2025 Rocky Mountain Liquor Amélioration De La Marge Brute Fermetures De Magasins Résultats Financiers 2025 Croissance De L'EBITDA Ajusté
BRIEF published on 04/28/2026 at 22:58, 4 months 13 days ago Pernod Ricard et Brown-Forman abandonnent leurs discussions de rapprochement PERNOD RICARD Spiritueux Stratégie Durable Brown-Forman Fusion Avortée
BRIEF published on 04/28/2026 at 22:58, 4 months 13 days ago Pernod Ricard and Brown-Forman End Merger Talks Spirits Industry Business Strategy PERNOD RICARD Merger Talks Brown-Forman
BRIEF published on 04/28/2026 at 22:58, 4 months 13 days ago Pernod Ricard and Brown-Forman abandon their merger talks PERNOD RICARD Sustainable Strategy Spirits Brown-Forman Aborted Merger
Published on 09/12/2026 at 02:35, 16 hours 54 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 20 hours 29 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 21 hours 24 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 22 hours 4 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 2 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 1 hour 38 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 11 hours 58 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 21 hours 14 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 21 hours 18 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 23 hours 44 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 1 day 12 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 12 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 23 hours ago Availability of the 2026 Interim Financial Report
